This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Soaps & Cleaning Stocks That are Braving Industry Challenges
by Vidya Nair
Pandemic-led rise in input costs are a headwind for several soap and cleaning materials companies. Nonetheless, strong demand for personal care items is a boon for players like Procter & Gamble (PG), Unilever (UL) and Church & Dwight (CHD).
Colgate (CL), Philips to Offer Electric Oral Care in Latin America
by Zacks Equity Research
Colgate (CL) and Philips come together to increase the usage of electric toothbrush in Latin America by launching a co-brand by the name of Philips Colgate.
Why Colgate-Palmolive (CL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Colgate-Palmolive (CL) Gains on High Demand Amid Cost Woes
by Zacks Equity Research
Although high costs and unfavorable currency remain concerns, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.
Colgate-Palmolive (CL) Cheers Investors With Dividend Hike
by Zacks Equity Research
Colgate (CL) gives investors another reason to cheer via a dividend hike of 2.3%. Its strong product demand and sturdy online show place it well for further growth.
Why Colgate-Palmolive (CL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Why Is Colgate-Palmolive (CL) Down 5% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This is Why Colgate-Palmolive (CL) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Top Research Reports for JPMorgan, Merck & NextEra
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase (JPM), Merck (MRK), and NextEra (NEE).
This is Why Colgate-Palmolive (CL) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Colgate's (CL) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
Colgate (CL) reports accelerated earnings and sales growth in fourth-quarter 2020 on strong demand for its products, innovation and positive e-commerce trends.
Colgate-Palmolive (CL) Q4 Earnings Match Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and 3.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Colgate (CL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Colgate (CL) is expected to have benefited from strong demand for personal and home care products as well as the finest innovation across product categories in Q4.
Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q2 Earnings & Sales Beat, FY21 View Up
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results gain from solid performance across all segments as well as a rise in organic shipment volumes, improved pricing and mix. Encouragingly, it lifts fiscal 2021 view.
Clorox (CLX) Up More Than 23% in a Year: What You Should Know
by Zacks Equity Research
Clorox's (CLX) IGNITE strategy, which targets boosting overall growth, bodes well. Notably, the company's cost-savings program is significantly contributing to gross margin expansion.
Why Colgate-Palmolive (CL) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Colgate-Palmolive (CL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will High Demand & Online Strength Continue to Aid Colgate (CL)?
by Zacks Equity Research
Despite cost and currency-related headwinds, strong product demand and sturdy online show are likely to help Colgate (CL) stay put amid this COVID-19 crisis.
4 Stocks to Tap Coronavirus-Led Pet Boom in 2021
by Zacks Equity Research
Consumers' home isolation trend stemming from the pandemic has been a huge accelerator for the pet industry. Tractor Supply (TSCO), Chewy (CHWY), Colgate (CL) and Spectrum Brands (SPB) look well poised.
3 Sector ETFs & Stocks to Shine Despite Soft November Retail Sales
by Sanghamitra Saha
Retail sales in the United States fell 1.1% sequentially in November 2020, following a revised 0.1% decline in October.
5 Soaps & Cleaning Products Stocks Worth a Look Amid Coronavirus Woes
by Vidya Nair
The COVID-led rising demand for hygiene products is a boon for several soap and cleaning materials companies such as Procter & Gamble (PG), Unilever (UL), Colgate (CL), Clorox (CLX) and Church & Dwight (CHD), However, rising input costs are a concern.
Colgate-Palmolive (CL) Up 10.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Colgate (CL) Benefiting From Healthy Consumer Good Demand?
by Zacks Equity Research
Colgate (CL) benefits from the increase in demand for personal and home care products due to the pandemic-led increase in hygiene habits.
Colgate (CL) Up on Q3 Earnings & Sales Beat, Gives Solid view
by Zacks Equity Research
Colgate (CL) reports accelerated earnings and sales growth in third-quarter 2020 on strong demand for its products, innovation and positive e-commerce trends.
Colgate-Palmolive (CL) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 12.86% and 4.60%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?